Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis

NCT03828123 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Interventions

BIOLOGICAL: Suspension of human autologous MSC 3P in 1.5 ml

Sponsor

Bioinova, s.r.o.

Collaborators

[object Object]